Genmab
GMAB
$27.60
Share price
-3.06%
Change (1 day)
-33.57%
Change (1 year)
Categories
Operating Margin for Genmab (GMAB)
Operating Margin as of April 2024 (TTM): 35.34%
According to Genmab's latest financial reports and stock price the company's current Operating Margin is 35.34%. At the end of 2022 the company had an Operating Margin of 48.20%.
Operating Margin history for Genmab from 2009 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 48.20% | 2.65% |
| 2021 | 46.96% | -19.58% |
| 2020 | 58.39% | 9.59% |
| 2019 | 53.28% | -0.01% |
| 2018 | 53.29% | 18.49% |
| 2017 | 44.97% | -27.74% |
| 2016 | 62.23% | -6.92% |
| 2015 | 66.86% | 91.21% |
| 2014 | 34.97% | 254.77% |
| 2013 | 9.86% | -141.87% |
| 2012 | -23.54% | -60.63% |
| 2011 | -59.79% | 184.24% |
| 2010 | -21.04% | -63.95% |
| 2009 | -58.35% | -54.92% |
| 2008 | -129.44% | 78.8% |
| 2007 | -72.40% | -77.61% |
| 2006 | -323.31% | -19.08% |
| 2005 | -399.56% | -103.95% |
| 2004 | 10,124.65% | 2014.36% |
| 2003 | 478.85% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.